Is Exelixis, Inc. overvalued?

Exelixis, Inc. (EXEL) looks fairly valued — trading about 6% below its fair value.

Fairly valued

Price

$69.00

Fair value

$73.17

Current P/E

20.7

Normal P/E

21.9

Market cap

$17.34B

Dividend yield

0.0%

Return on equity

45.5%

Sector

Healthcare

Fair value compares EXEL's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.

Related stocks